Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2022
/
Article
/
Tab 2
/
Research Article
Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma
Table 2
Comparison of serum indices after treatment (
).
Groups
PSA (ng/ml)
VEGF (pg/ml)
Experimental group
45
Control group
45
17.737
4.799
<0.001
<0.001